Mallmann-Gottschalk, N.; Sax, Y.; Kimmig, R.; Lang, S.; Brandau, S.
EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells. Int. J. Mol. Sci. 2019, 20, 4693.
https://doi.org/10.3390/ijms20194693
AMA Style
Mallmann-Gottschalk N, Sax Y, Kimmig R, Lang S, Brandau S.
EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells. International Journal of Molecular Sciences. 2019; 20(19):4693.
https://doi.org/10.3390/ijms20194693
Chicago/Turabian Style
Mallmann-Gottschalk, Nina, Yvonne Sax, Rainer Kimmig, Stephan Lang, and Sven Brandau.
2019. "EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells" International Journal of Molecular Sciences 20, no. 19: 4693.
https://doi.org/10.3390/ijms20194693
APA Style
Mallmann-Gottschalk, N., Sax, Y., Kimmig, R., Lang, S., & Brandau, S.
(2019). EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells. International Journal of Molecular Sciences, 20(19), 4693.
https://doi.org/10.3390/ijms20194693